OR WAIT null SECS
May 22, 2014
Kymab receives $40 million investment for clinical development of antibody therapeutics.
May 19, 2014
AstraZeneca rejects Pfizer's final offer of $118 billion for a proposed merger of the two companies.
May 08, 2014
Tigermed acquires Frontage Laboratories for $50.25 million.
The Fogarty International Center, a component of the US NIH, calls for a focus on noncommunicable diseases and implementing science in low-resource settings.
May 02, 2014
Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.
Bristol-Myers Squibb is named No. 1 on 2014 Best Corporate Citizens List for the third time in six years.
Eli Lilly has developed the Lilly Medical Student Intern Program for future physicians.
Novartis' eBook features images of meningococcal disease survivors from around the world.
April 23, 2014
UPM will commercially manufacture two ANDA products for Amerigen Pharmaceuticals.
April 22, 2014
Portfolio swaps between Novartis and GSK involve oncology, vaccines, and consumer products.